In an April 27 letter to HHS Secretary Xavier Becerra, the Texas Congressional Delegation said CMS’ decision to revoke the waiver “threatens the security of the state’s Medicaid program, disrespects continuity of this agreement, and erodes the partnership between the state and CMS.”
CMS revoked its approval of the 10-year waiver extension in an April 16 notice to the Texas Health and Human Services Commission. CMS argued that under the previous administration — which approved Texas’ waiver to extend parts of its Medicaid program through September 2030 — CMS and Texas failed to adhere to public comment period requirements in the approval process. CMS said the public comment period is necessary for stakeholders to share feedback.
The Texas lawmakers argued the time needed to negotiate a new waiver will detract from other health priorities at the state and federal level, and urged CMS to reconsider its decision in addition to working “closely with Texas going forward.”
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
